ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
COVID-19 vaccine candidate gets green light for trial in China
July 16, 2020The COVID-19 vaccine candidate, BNT162b1, has been approved for clinical trial registration by China’s National Medical Products Administration (NMPA). -
FDA grants fast track status to Pfizer and BioNTech Covid-19 vaccines
July 15, 2020Pfizer and BioNTech have received fast track designation from the US Food and Drug Administration (FDA) for two of their four potential Covid-19 vaccines. -
Pfizer, BioNTech post positive data from study of COVID-19 vaccine candidate
July 02, 2020If studies are successful and mRNA-based vaccine candidate receives regulatory approval, companies expect to manufacture up to 100 million doses by the end of 2020 and potentially more than 1.2 billion doses by the end of 2021.
Pharma Sources Insight January 2025
